Literature DB >> 28453871

Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria.

E Shabani1,2, B J Ouma3, R Idro4, P Bangirana5, R O Opoka4, G S Park6, A L Conroy2, C C John1,2.   

Abstract

Systemic tumour necrosis factor-α (TNF-α) may contribute to the pathogenesis of cerebral malaria (CM) by promoting endothelial activation and parasite sequestration. However, less is known about the role of central nervous system (CNS) TNF-α in CM. We assessed plasma (n=249) and cerebrospinal fluid (CSF) (n=167) TNF-α levels in Ugandan children with CM, plasma TNF-α in Ugandan community control children (n=198) and CSF TNF-α in North American control children who had recovered from leukaemia (n=13). Plasma and CSF TNF-α were measured by magnetic bead assay. We compared plasma and CSF TNF-α levels in children with CM to mortality, acute and chronic neurologic deficits and long-term neurocognitive impairment. Plasma and CSF TNF-α levels were higher in CM than control children (P<.0001 for both). CSF TNF-α levels were higher in children who had neurologic deficits at discharge or 6-month follow-up (P≤.05 for both). Elevated CSF but not plasma TNF-α was associated with longer coma duration (Spearman's rho .18, P=.02) and deficits in overall cognition in children 5 years and older (β coefficient -.74, 95% CI -1.35 to -0.13, P=.02). The study findings suggest that CNS TNF-α may be involved in the development of acute and chronic neurologic and cognitive sequelae in children with CM.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  neurocognitive impairment; paediatric cerebral malaria; tumour necrosis factor-alpha

Mesh:

Substances:

Year:  2017        PMID: 28453871      PMCID: PMC5492989          DOI: 10.1111/pim.12438

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  48 in total

1.  Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta.

Authors:  I Y Chung; E N Benveniste
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

2.  Clinical Comparison of Retinopathy-Positive and Retinopathy-Negative Cerebral Malaria.

Authors:  Chandler Villaverde; Ruth Namazzi; Estela Shabani; Robert O Opoka; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

3.  The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria.

Authors:  M B van Hensbroek; A Palmer; E Onyiorah; G Schneider; S Jaffar; G Dolan; H Memming; J Frenkel; G Enwere; S Bennett; D Kwiatkowski; B Greenwood
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

4.  Developmental normative data on the test of variables of attention (T.O.V.A.).

Authors:  L M Greenberg; I D Waldman
Journal:  J Child Psychol Psychiatry       Date:  1993-09       Impact factor: 8.982

5.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

6.  Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes.

Authors:  I M Medana; N H Hunt; G Chaudhri
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

7.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Authors:  G Boka; P Anglade; D Wallach; F Javoy-Agid; Y Agid; E C Hirsch
Journal:  Neurosci Lett       Date:  1994-05-19       Impact factor: 3.046

8.  Cerebral malaria in children is associated with long-term cognitive impairment.

Authors:  Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin
Journal:  Pediatrics       Date:  2008-06-09       Impact factor: 7.124

9.  Cerebral malaria in children: serum and cerebrospinal fluid TNF-alpha and TGF-beta levels and their relationship to clinical outcome.

Authors:  Fabian Esamai; Jan Ernerudh; Helena Janols; Susanne Welin; Christina Ekerfelt; Simeon Mining; Pia Forsberg
Journal:  J Trop Pediatr       Date:  2003-08       Impact factor: 1.165

10.  Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.

Authors:  Michael Walther; David Jeffries; Olivia C Finney; Madi Njie; Augustine Ebonyi; Susanne Deininger; Emma Lawrence; Alfred Ngwa-Amambua; Shamanthi Jayasooriya; Ian H Cheeseman; Natalia Gomez-Escobar; Joseph Okebe; David J Conway; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more
  14 in total

1.  Evaluating Immunopathogenic Biomarkers During Severe Malaria Illness as Modifiers of the Neuropsychologic Benefits of Computer Cognitive Games Rehabilitation in Ugandan Children.

Authors:  Michael J Boivin; Alla Sikorskii; Noeline Nakasujja; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Robert O Opoka; Bruno Giordani
Journal:  Pediatr Infect Dis J       Date:  2019-08       Impact factor: 2.129

2.  Elevated Cerebrospinal Fluid Tau Protein Concentrations on Admission Are Associated With Long-term Neurologic and Cognitive Impairment in Ugandan Children With Cerebral Malaria.

Authors:  Dibyadyuti Datta; Andrea L Conroy; Peter F Castelluccio; John M Ssenkusu; Gregory S Park; Robert O Opoka; Paul Bangirana; Richard Idro; Andrew J Saykin; Chandy C John
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

Review 3.  Pathophysiology, clinical presentation, and treatment of coma and acute kidney injury complicating falciparum malaria.

Authors:  Katherine Plewes; Gareth D H Turner; Arjen M Dondorp
Journal:  Curr Opin Infect Dis       Date:  2018-02       Impact factor: 4.915

4.  Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria.

Authors:  Valerie M Crowley; Kodjo Ayi; Ziyue Lu; Karen T Liby; Michael Sporn; Kevin C Kain
Journal:  Malar J       Date:  2017-11-14       Impact factor: 2.979

Review 5.  Cytokines and Chemokines in Cerebral Malaria Pathogenesis.

Authors:  Josefine Dunst; Faustin Kamena; Kai Matuschewski
Journal:  Front Cell Infect Microbiol       Date:  2017-07-20       Impact factor: 5.293

6.  Brain swelling is independent of peripheral plasma cytokine levels in Malawian children with cerebral malaria.

Authors:  Visopo Harawa; Madi Njie; Anne Kessler; Augustine Choko; Benjamin Kumwenda; Sam Kampondeni; Michael Potchen; Kami Kim; Anthony Jaworowski; Terrie Taylor; Wilson Mandala; Karl Seydel; Stephen Rogerson
Journal:  Malar J       Date:  2018-11-26       Impact factor: 2.979

7.  What causes severe malaria and its complications in children? Lessons learned over the past 15 years.

Authors:  Andrea L Conroy; Dibyadyuti Datta; Chandy C John
Journal:  BMC Med       Date:  2019-03-07       Impact factor: 8.775

8.  Human Microglia Respond to Malaria-Induced Extracellular Vesicles.

Authors:  Smart Ikechukwu Mbagwu; Nils Lannes; Michael Walch; Luis Filgueira; Pierre-Yves Mantel
Journal:  Pathogens       Date:  2019-12-24

9.  Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature.

Authors:  Nadia Castaldo; Carlo Tascini; Paola Della Siega; Maddalena Peghin; Davide Pecori
Journal:  Malar J       Date:  2020-11-23       Impact factor: 2.979

Review 10.  Predictors of outcome in childhood Plasmodium falciparum malaria.

Authors:  Harsita Patel; Claire Dunican; Aubrey J Cunnington
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.